As ferroptosis induction by ibrutinib appeared heterogeneous across primary CLL samples, we next investigated whether lipid peroxidation levels induced by ibrutinib alone or in combination with the GPX4 inhibitor ML162 were correlated with ferroptotic cell death. Here, GPX4 is linked to B-cell chronic lymphocytic leukemia.